Suchergebnisse - "Dudnik, Elizabeth"

PubPharm (75)

21

Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Icht, O. | Darzi, N. | Shimony, S. | +13

22

Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer

enthalten in: Asia-Pacific journal of clinical oncology | 2021

von Icht, O. | Domachevsky, L. | Groshar, D. | +9

23

Multicentric non-enhancing lesions in glioblastoma : A retrospective study

enthalten in: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia | 2021

von Benouaich-Amiel, A. | Khasminsky, V. | Gal, O. | +9

24

Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer : A real-world evidence

enthalten in: International journal of cancer | 2021

von Dudnik, E. | Moskovitz, M. | Agbarya, A. | +11

25

Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

enthalten in: Journal for immunotherapy of cancer | 2021

von Dudnik, E. | Kareff, S. | Moskovitz, M. | +11

26

Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC : a retrospective chart review (REFLECT)

enthalten in: Therapeutic advances in medical oncology | 2021

von Addeo, A. | Hochmair, M. | Janzic, U. | +9

27

Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50% : real-world data

enthalten in: Oncoimmunology | 2021

von Dudnik, E. | Moskovitz, M. | Rottenberg, Y. | +11

28

Nivolumab in Non-Small Cell Lung Cancer : Real World Long-Term Survival Results and Blood-Based Efficacy Biomarkers

enthalten in: Frontiers in oncology | 2021

von Daher, S. | Lawrence, Y. | Dudnik, E. | +10

29

BAP1-Altered Malignant Pleural Mesothelioma : Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors

enthalten in: Frontiers in oncology | 2021

von Dudnik, E. | Bar, J. | Moore, A. | +9

30

Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer

enthalten in: Oncoimmunology | 2021

von Landman, Y. | Jacobi, O. | Kurman, N. | +6